Regulatory status: IVD, FDA Class I
60-0093-7 7mL RTU
61-0093 1mL concentrate
This antibody is useful for subtyping lymphomas and lymphatic leukemia in a panel of antibodies. Paired box 5 (PAX5) is expressed in B-cell non-Hodgkin’s lymphoma (B-NHL), Hodgkin’s lymphoma (HL) and neuroendocrine tumors.